Table 2 Prescription persistence rate of evocalcet and prescription status of intravenous drugs for SHPT
Evocalcet and intravenous drugs for SHPT | BL n = 147 | 1 year n = 133 | 3 year n = 100 | 5 year n = 76 | |
|---|---|---|---|---|---|
Evocalcet | n (%) | 147 (100) | 115 (86.5) | 68 (68.0) | 42 (55.3) |
Intravenous calcitriol | n (%) | 54 (36.7) | 51 (38.3) | 35 (35.0) | 25 (32.9) |
Maxacalcitol | n (%) | 42 (28.6) | 47 (35.3) | 41 (41.0) | 32 (42.1) |
Etelcalcetide hydrochloride | n (%) | 0 (0) | 7 (5.3) | 15 (15.0) | 22 (28.9) |
None | n (%) | 0 (0) | 4 (3.0) | 7 (7.0) | 3 (3.9) |